Viatris shares favorable Phase 3 data for contraceptive patch and pain drug, affirms 2025 sales, and raises adjusted EPS ...

The opioid epidemic has prompted a re-evaluation of pain-management strategies, highlighting the importance of balancing effective treatm ...